Retention of mechanical properties of phosphate glass fibre reinforced degradable polyesters such as polycaprolactone and polylactic acid in aqueous media has been shown to be strongly influenced by the integrity of the fibre/polymer interface. A previous study utilising ‘single fibre’ fragmentation tests found that coating with magnesium improved the fibre and matrix interfacial shear strength. Therefore, the aim of this study was to investigate the effects of a magnesium coating on the manufacture and characterisation of a random chopped fibre reinforced polycaprolactone composite. Short chopped strand non-woven phosphate glass fibre mats were sputter coated with degradable magnesium to manufacture phosphate glass fibre/polycaprolactone composites. The degradation behaviour (water uptake, mass loss and pH change of the media) of these polycaprolactone composites as well as of pure polycaprolactone was investigated in phosphate buffered saline. The Mg coated fibre reinforced composites revealed less water uptake and mass loss during degradation compared to the non-coated composites. The cations released were also explored and a lower ion release profile for all three cations investigated (namely Na+, Mg2+ and Ca2+) was seen for the Mg coated composite samples. An increase of 17% in tensile strength and 47% in tensile modulus was obtained for the Mg coated composite samples. Both flexural and tensile properties were investigated and a higher retention of mechanical properties was obtained for the Mg coated fibre reinforced composite samples up to 10 days immersion in PBS. Cytocompatibility study showed both composite samples (coated and non-coated) had good cytocompatibility with human osteosarcoma cell line.
DashTKKonkimallaVB. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: a review. J Controlled Release2012; 158: 15–33.
2.
WoodruffMAHutmacherDW. The return of a forgotten polymer-Polycaprolactone in the 21st century. Progress Polymer Sci2010; 35: 1217–1256.
3.
PorterJRHensonAPopatKC. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. Biomaterials2009; 30: 780–788.
4.
Gunatillake PA and Adhikari R. Biodegradable synthetic polymers for tissue engineering. European Cells Mater 2003; 5: 1–16; discussion.
5.
Van de VeldeKKiekensP. Biopolymers: overview of several properties and consequences on their applications. Polymer Test2002; 21: 433–442.
6.
EshraghiSDasS. Mechanical and microstructural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sintering. Acta Biomaterialia2010; 6: 2467–2476.
7.
HarperLTAhmedIFelfelRM. Finite element modelling of the flexural performance of resorbable phosphate glass fibre reinforced PLA composite bone plates. J Mech Behav Biomed2012; 15: 13–23.
8.
AzevedoMCReisRLClaaseBM. Development and properties of polycaprolactone/hydroxyapatite composite biomaterials. J Mater Sci – Mater Med2003; 14: 103–107.
9.
ArafatMTLamCXFEkaputraAK. High performance additive manufactured scaffolds for bone tissue engineering application. Soft Matter2011; 7: 8013–8022.
10.
GuptaKKKundanAMishraPK. Polycaprolactone composites with TiO2 for potential nanobiomaterials: tunable properties using different phases. Phys Chem Chem Phys2012; 14: 12844–12853.
11.
JoJHLeeEJShinDS. In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(epsilon-caprolactone) composite materials. J Biomed Mater Res B2009; 91B: 213–220.
12.
PrabhakarRLBrocchiniSKnowlesJC. Effect of glass composition on the degradation properties and ion release characteristics of phosphate glass – polycaprolactone composites. Biomaterials2005; 26: 2209–2218.
13.
XieJBloughERWangC-H. Submicron bioactive glass tubes for bone tissue engineering. Acta Biomaterialia2012; 8: 811–819.
14.
LeiBShinKHNohDY. Bioactive glass microspheres as reinforcement for improving the mechanical properties and biological performance of poly(e-caprolactone) polymer for bone tissue regeneration. J Biomed Mater Res B2012; 100B: 967–975.
15.
AhmedIParsonsAJPalmerG. Weight loss, ion release and initial mechanical properties of a binary calcium phosphate glass fibre/PCL composite. Acta Biomaterialia2008; 4: 1307–1314.
16.
JukolaHNikkolaLGomesME. Development of a bioactive glass fiber reinforced starch-polycaprolactone composite. J Biomed Mater Res B2008; 87B: 197–203.
17.
JiangGEvansMEJonesIA. Preparation of poly(ɛ-caprolactone)/continuous bioglass fibre composite using monomer transfer moulding for bone implant. Biomaterials2005; 26: 2281–2288.
18.
Yang XB, Lu X, Ge JJ, et al. Effect of a silane coupling agent on mechanical properties of hydroxyapatite/polycaprolactone composites. Bioceramics, 2008;20 (Pts 1 and 2); 361–363, 531–534.
19.
StaigerMPPietakAMHuadmaiJ. Magnesium and its alloys as orthopedic biomaterials: a review. Biomaterials2006; 27: 1728–1734.
20.
SarisNELMervaalaEKarppanenH. Magnesium – an update on physiological, clinical and analytical aspects. Clin Chim Acta2000; 294: 1–26.
21.
RudeRKGruberHE. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem2004; 15: 710–716.
22.
Liu X, Grant DM, Parsons AJ, et al. Magnesium coated bioresorbable phosphate glass fibres: investigation of the interface between fibre and polyester matrices. BioMed Res Int 2013: 10.
23.
ASTM Standard D2584-94. Test method for ignition loss of cured reinforced resins West Conshohocken, PA.1994.
24.
BS 2782-10: METHOD 1005: 1977, EN 63: 1977. Methods of testing plastics. Glass reinforced plastics. Determination of flexural properties. Three point method, 1977.
25.
BS EN ISO 527-2: 1996, BS 2782-3: Method 322: 1994. Determination of tensile property – part 2. Test condition of moulding and extrusion plastics, 1994.
26.
Na Han, Ifty Ahmed, Andrew J Parsons, et al. Influence of screw holes and gamma sterilization on properties of phosphate glass fiber-reinforced composite bone plates. J Biomater Appl 2013; 27(8): 990–1002.
27.
ParsonsAJAhmedIHaqueP. Phosphate glass fibre composites for bone repair. J Bionic Eng2009; 6: 318–323.
28.
FelfelRMAhmedIParsonsAJ. Initial mechanical properties of phosphate-glass fibre-reinforced rods for use as resorbable intramedullary nails. J Mater Sci2012; 47: 4884–4894.
29.
FelfelRMAhmedIParsonsAJ. Investigation of crystallinity, molecular weight change, and mechanical properties of PLA/PBG bioresorbable composites as bone fracture fixation plates. J Biomater Appl2012; 26: 765–789.
30.
SlivkaMAChuCC. Fiber-matrix interface studies on bioabsorbable composite materials for internal fixation of bone fractures. 2. A new method using laser scanning confocal microscopy. J Biomed Mater Res1997; 37: 353–362.
31.
LehtonenTJTuominenJUHiekkanenE. Resorbable composites with bioresorbable glass fibers for load-bearing applications. In vitro degradation and degradation mechanism. Acta Biomaterialia2013; 9: 4868–4877.
32.
AhmedICroninPSAbou NeelEA. Retention of mechanical properties and cytocompatibility of a phosphate-based glass fiber/polylactic acid composite. J Biomed Mater Res B2009; 89B: 18–27.
33.
FelfelRMAhmedIParsonsAJ. Cytocompatibility, degradation, mechanical property retention and ion release profiles for phosphate glass fibre reinforced composite rods. Mat Sci Eng C – Mater2013; 33: 1914–1924.
34.
GaoHSTanTNWangDH. Dissolution mechanism and release kinetics of phosphate controlled release glasses in aqueous medium. J Controlled Release2004; 96: 29–36.
35.
Bao T and Tanaka J. The diffusion of ions in polyethylene. In: Proceedings of the 3rd international conference on properties and applications of dielectric materials, Vols 1 and 2, Tokyo, Japan, 1991, pp.236–239.
36.
AlaniAKnowlesJCChrzanowskiW. Ion release characteristics, precipitate formation and sealing ability of a phosphate glass–polycaprolactone-based composite for use as a root canal obturation material. Dental Mater2009; 25: 400–410.
37.
Jones JR and Clare AG. Bio-glasses: an introduction. Hoboken, New Jersey: John Wiley & Sons, 2012, pp.5–11.
38.
WalterGVogelJHoppeU. The structure of CaO–Na2O–MgO–P2O5 invert glass. J Non-Cryst Solids2001; 296: 212–223.
39.
MohammadiMSAhmedIMujaN. Effect of Si and Fe doping on calcium phosphate glass fibre reinforced polycaprolactone bone analogous composites. Acta Biomaterialia2012; 8: 1616–1626.
40.
Abou NeelEAAhmedIBlakerJJ. Effect of iron on the surface, degradation and ion release properties of phosphate-based glass fibres. Acta Biomaterialia2005; 1: 553–563.
41.
CordenTJJonesIARuddCD. Physical and biocompatibility properties of poly-epsilon-caprolactone produced using in situ polymerisation: a novel manufacturing technique for long-fibre composite materials. Biomaterials2000; 21: 713–724.
42.
AhmedICollinsCALewisMP. Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering. Biomaterials2004; 25: 3223–3232.
43.
BrarHSPlattMOSarntinoranontM. Magnesium as a biodegradable and bioabsorbable material for medical implants. Jom-Us2009; 61: 31–34.
44.
WoodruffMAHutmacherDW. The return of a forgotten polymer–Polycaprolactone in the 21st century. Prog Polymer Science2010; 35: 1217–1256.
45.
HasanMSAhmedIParsonsAJ. Material characterisation and cytocompatibility assessment of quinternary phosphate glasses. J Mater Sci – Mater M2012; 23: 2531–2541.
46.
Abou NeelEAKnowlesJC. Physical and biocompatibility studies of novel titanium dioxide doped phosphate-based glasses for bone tissue engineering applications. J Mater Sci – Mater M2008; 19: 377–386.
47.
HasanMSAhmedIParsonsAJ. Material characterisation and cytocompatibility assessment of quinternary phosphate glasses. J Mater Sci: Mater Med2012; 23: 2531–2541.
48.
HasanMAhmedIParsonsA. Cytocompatibility and mechanical properties of short phosphate glass fibre reinforced polylactic acid (PLA) composites: effect of coupling agent mediated interface. J Func Biomater2012; 3: 706–725.
49.
HasanMSAhmedIParsonsAJ. The influence of coupling agents on mechanical property retention and long-term cytocompatibility of phosphate glass fibre reinforced PLA composites. J Mech Behavior Biomed Mater2013; 28: 1–14.
50.
ZreiqatHHowlettCRZannettinoA. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomedical Mat Res2002; 62: 175–184.
51.
MurphySWrenAWTowlerMR. The effect of ionic dissolution products of Ca-Sr-Na-Zn-Si bioactive glass on in vitro cytocompatibility. J Mater Sci Mater Med2010; 21: 2827–2834.
HallabNJVermesCMessinaC. Concentration- and composition-dependent effects of metal ions on human MG-63 osteoblasts. J Biomed Mater Res2002; 60: 420–433.
54.
XynosIDEdgarAJButteryLDK. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution. J Biomed Mater Res2001; 55: 151–157.
